Epitomee Medical Ltd
EPTMF
$0.9892
-$0.0327-3.20%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 744.00K | 744.00K | 833.00K | 971.00K | 971.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 58.00K | -- | -- |
| Total Operating Expenses | 2.27M | 2.27M | 2.18M | 2.39M | 2.39M |
| Operating Income | -2.27M | -2.27M | -2.18M | -2.39M | -2.39M |
| Income Before Tax | -1.79M | -1.79M | -2.30M | -2.68M | -2.68M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.79M | -1.79M | -2.30M | -2.68M | -2.68M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.79M | -1.79M | -2.30M | -2.68M | -2.68M |
| EBIT | -2.27M | -2.27M | -2.18M | -2.39M | -2.39M |
| EBITDA | -2.04M | -2.04M | -2.06M | -2.29M | -2.29M |
| EPS Basic | -0.06 | -0.06 | -0.08 | -0.09 | -0.09 |
| Normalized Basic EPS | -0.04 | -0.04 | -0.05 | -0.05 | -0.05 |
| EPS Diluted | -0.06 | -0.06 | -0.08 | -0.09 | -0.09 |
| Normalized Diluted EPS | -0.04 | -0.04 | -0.05 | -0.05 | -0.05 |
| Average Basic Shares Outstanding | 29.81M | 29.81M | 29.80M | 29.76M | 29.76M |
| Average Diluted Shares Outstanding | 29.81M | 29.81M | 29.80M | 29.76M | 29.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |